DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,465 | +17.8% | 584,165 | +28.5% | 0.39% | +16.6% |
| Q2 2023 | $109,072 | -20.9% | 454,466 | -16.9% | 0.34% | -28.9% |
| Q1 2023 | $137,809 | +5.3% | 546,773 | +10.9% | 0.47% | -4.2% |
| Q4 2022 | $130,825 | -99.9% | 492,900 | -8.4% | 0.50% | -15.8% |
| Q3 2022 | $138,990,000 | +24.3% | 538,114 | +22.0% | 0.59% | +19.5% |
| Q2 2022 | $111,792,000 | -24.5% | 440,962 | -12.6% | 0.49% | -12.9% |
| Q1 2022 | $148,045,000 | -6.0% | 504,704 | +5.5% | 0.56% | -6.0% |
| Q4 2021 | $157,456,000 | +31.1% | 478,575 | +21.3% | 0.60% | +21.7% |
| Q3 2021 | $120,078,000 | +105.2% | 394,422 | +80.8% | 0.49% | +81.0% |
| Q2 2021 | $58,530,000 | +26.3% | 218,102 | +5.9% | 0.27% | +12.8% |
| Q1 2021 | $46,333,000 | +5.7% | 205,854 | +4.4% | 0.24% | -4.0% |
| Q4 2020 | $43,814,000 | +3.7% | 197,234 | +0.5% | 0.25% | -5.3% |
| Q3 2020 | $42,252,000 | +11.9% | 196,218 | -8.1% | 0.27% | +6.0% |
| Q2 2020 | $37,763,000 | +41.5% | 213,554 | +10.7% | 0.25% | +15.1% |
| Q1 2020 | $26,693,000 | -17.1% | 192,856 | -8.1% | 0.22% | -4.0% |
| Q4 2019 | $32,208,000 | +12.7% | 209,853 | +6.1% | 0.23% | 0.0% |
| Q3 2019 | $28,570,000 | +9.8% | 197,814 | +8.7% | 0.23% | +7.1% |
| Q2 2019 | $26,011,000 | +11.0% | 181,995 | +2.5% | 0.21% | +3.4% |
| Q1 2019 | $23,434,000 | -40.6% | 177,506 | -53.6% | 0.20% | +5.1% |
| Q4 2018 | $39,438,000 | +88.9% | 382,466 | +99.1% | 0.20% | +6.0% |
| Q3 2018 | $20,874,000 | -44.2% | 192,111 | -49.3% | 0.18% | +2.8% |
| Q2 2018 | $37,396,000 | +111.2% | 378,962 | +109.6% | 0.18% | +2.3% |
| Q1 2018 | $17,703,000 | +14.9% | 180,814 | +8.9% | 0.18% | +11.5% |
| Q4 2017 | $15,414,000 | +10.1% | 166,070 | +1.8% | 0.16% | +6.1% |
| Q3 2017 | $13,999,000 | +30.0% | 163,196 | +27.9% | 0.15% | +26.5% |
| Q2 2017 | $10,769,000 | +5.0% | 127,604 | +6.4% | 0.12% | +2.6% |
| Q1 2017 | $10,260,000 | +16.1% | 119,958 | +5.7% | 0.11% | +7.5% |
| Q4 2016 | $8,836,000 | -15.8% | 113,503 | -15.2% | 0.11% | -22.1% |
| Q3 2016 | $10,494,000 | -7.1% | 133,872 | -9.3% | 0.14% | -12.8% |
| Q2 2016 | $11,293,000 | -24.1% | 147,527 | -5.9% | 0.16% | -30.0% |
| Q1 2016 | $14,877,000 | +27.6% | 156,838 | +25.0% | 0.22% | +16.8% |
| Q4 2015 | $11,657,000 | +31.7% | 125,507 | +20.8% | 0.19% | +24.0% |
| Q3 2015 | $8,853,000 | +11.0% | 103,899 | +11.5% | 0.15% | +14.1% |
| Q2 2015 | $7,973,000 | +4.7% | 93,157 | +3.8% | 0.14% | +0.7% |
| Q1 2015 | $7,616,000 | +4.6% | 89,708 | +5.6% | 0.13% | -1.5% |
| Q4 2014 | $7,281,000 | -9.4% | 84,955 | -19.7% | 0.14% | -15.5% |
| Q3 2014 | $8,033,000 | +14.0% | 105,732 | +18.2% | 0.16% | +59.4% |
| Q2 2014 | $7,046,000 | +19.9% | 89,487 | +14.2% | 0.10% | +12.2% |
| Q1 2014 | $5,876,000 | -6.5% | 78,344 | -3.7% | 0.09% | -12.6% |
| Q4 2013 | $6,282,000 | +6.4% | 81,376 | -4.5% | 0.10% | -5.5% |
| Q3 2013 | $5,903,000 | +39.8% | 85,169 | +27.7% | 0.11% | +29.8% |
| Q2 2013 | $4,223,000 | – | 66,717 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |